2022
DOI: 10.1016/j.phrs.2022.106056
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of intestinal barrier function by glucocorticoids: Lessons from preclinical models

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(22 citation statements)
references
References 130 publications
0
15
0
Order By: Relevance
“…This can be explained, on the one hand, by the increased expression of fibronectin (only in Nthy-ori 3-1 cells) and, on the other hand, by an increased formation of TJs, which was particularly observed in metastatic FTC-133 and WRO cells. Glucocorticoid-induced TJ formation and re-organization has been previously described and studied in mouse mammary epithelial cells [ 69 , 70 ] and in preclinical human intestinal models (summarized in [ 71 ]). In our experiments, the RPM also increased the expression of TJ proteins claudin-1 and ZO-1, as well as the formation of TJs, which had an enhancing effect when combined with DEX treatment.…”
Section: Discussionmentioning
confidence: 99%
“…This can be explained, on the one hand, by the increased expression of fibronectin (only in Nthy-ori 3-1 cells) and, on the other hand, by an increased formation of TJs, which was particularly observed in metastatic FTC-133 and WRO cells. Glucocorticoid-induced TJ formation and re-organization has been previously described and studied in mouse mammary epithelial cells [ 69 , 70 ] and in preclinical human intestinal models (summarized in [ 71 ]). In our experiments, the RPM also increased the expression of TJ proteins claudin-1 and ZO-1, as well as the formation of TJs, which had an enhancing effect when combined with DEX treatment.…”
Section: Discussionmentioning
confidence: 99%
“…However, the effects of GC on the intestinal epithelial barrier are still unclear. 30 Clinical studies have shown that high-dose of corticosteroids can significantly increase the permeability of the duodenum. 31 Similarly, preclinical studies reached the same conclusions, noting that in colitis-afflicted mice, GCs such as budesonide, had anti-inflammatory effects, but simultaneously compromising the integrity of the intestinal mucosal barrier.…”
Section: Discussionmentioning
confidence: 99%
“…They are commonly utilized in clinical practice as anti-inflammatory and immunosuppressive drugs. However, the effects of GC on the intestinal epithelial barrier are still unclear . Clinical studies have shown that high-dose of corticosteroids can significantly increase the permeability of the duodenum .…”
Section: Discussionmentioning
confidence: 99%
“…In this perspective, the use of glucocorticoids , which exert potent anti-inflammatory actions, has a theoretical basis. Glucocorticoids use in diverse preclinical models of intestinal barrier injury has given contradictory results, and negative effects on gut barrier function have been attributed, at least partly, on their negative impact on mucus production and epithelial healing [ 91 ]. However, preclinical studies on sepsis have demonstrated a positive impact of glucocorticoids based on their anti-inflammatory action, and their TJs preserving effect [ 12 ].…”
Section: Therapeutic Approaches Targeting the Gut Barriermentioning
confidence: 99%